The device acts on the supraorbital nerve and supratrochlear nerve, the nerves that transmit migraine pain. The Food and Drug Administration (FDA) has cleared WAT Medical’s HeadaTerm 2 as an ...

Significant reduction seen in median headache days per month in both intractable and nonintractable migraine groups. HealthDay News — For pediatric patients with migraine, prophylactic zonisamide use ...

Preventive antimigraine therapy (PAM) should probably not be considered until the headache frequency exceeds 1 per week. PAM is associated with significant side effects and often with tachyphylaxis ...

Eptinezumab-jjmr, the fourth CGRP antagonist, was approved by the FDA in February 2020 as the first anti-CGRP agent for intravenous therapy, which differs distinctively from the other agents. 35 In ...

Beta-blockers. Propranolol, timolol, nadolol, atenolol, and metoprolol are among the beta-blockers that have been used to prevent migraine headaches. As a general principle, patients should be ...

September 7, 2006 -- Oral rizatriptan ( Maxalt, Merck) is a highly effective and well-tolerated treatment for migraine attacks in children and adolescents, a new study suggests. In a double-blind, ...

Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis asset VRG-145 BUDAPEST, HUNGARY, January 9 ...

"Effect of Different Meditation Types on Migraine Headache Medication Use," an article recently published in Behavioral Medicine, examines whether or not, and to what extent, a combination of ...

Headache is a common complaint of children and adolescents. Pediatric headaches may occur due to a variety of causes, including migraine and tension-type headaches (TTH), as well as secondary origins.